Fluconazole 2mg/mL; soln for IV infusion. All doses are once daily. Oropharyngeal candidiasis: 200mg on Day 1, then 100mg/day for at least 2 weeks. Esophageal candidiasis: 200mg on Day 1, then ...

BEDFORD, Ohio, Jan. 14 Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., is pleased to announce FDA approval for the addition of 100 mg/50 mL Fluconazole Injection to its existing ...

The batch was distributed between August 14, 2018 and September 5, 2018. Sagent announced a voluntary recall of 1 lot of Fluconazole Injection, USP, 200mg/100mL due to the discovery of an out of ...

The FDA released a safety announcement alerting health care professionals and patients of a voluntary recall on one lot of fluconazole injection, USP (in 0.9% sodium chloride), 200 mg/100 mL, after ...

SCHAUMBURG, Ill., Aug. 27 Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched fluconazole injection in premix bags. IMS Health ...

Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Fluconazole Injection, USP, (in 0.9% Sodium Chloride) 200mg per 100mL flexible container bag (NDC ...

Claris Lifesciences Ltd has informed BSE regarding a Press Release dated April 21, 2015 titled "Claris receives Supplemental ANDA approval for Fluconazole Injection in 50 ml PVC Bags"Source : BSE ...

Sagent Pharmaceuticals issues a nationwide recall of Fluconazole injection, USP, due to out of specification impurity results. On March 1, 2016, Sagent Pharmaceuticals announced that it was recalling ...

Fluconazole injection in 50 ml PVC bags, is used for treating fungal infections, in the American market Claris Lifesciences has received supplemental approval from the US health regulator to market ...

Fluconazole is the generic equivalent of Pfizer's Diflucan. On Friday, Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA)JERUSALEM--(BUSINESS WIRE)--Jan. 14, 2005--Teva Pharmaceutical ...

Shares of Claris Lifesciences jumped more than 4 percent intraday on Tuesday on supplemental ANDA approval for antifungal medicine. Advisory Alert: It has come to our attention that certain ...